Axsome Therapeutics, Inc. (AXSM) earnings date
Feb 22, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 35 days, typically, give or take 8 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Nov 2, 2026 | before open | 33 | 8-K |
| Q2 FY2026 | Mon, Aug 10, 2026 | before open | 41 | 8-K |
| Q1 FY2026 | Mon, May 4, 2026 | before open | 34 | 8-K |
| Q4 FY2025 | Mon, Feb 23, 2026 | before open | 54 | 8-K |
| Q3 FY2025 | Mon, Nov 3, 2025 | before open | 34 | 8-K |
| Q2 FY2025 | Mon, Aug 4, 2025 | before open | 35 | 8-K |
| Q1 FY2025 | Mon, May 5, 2025 | before open | 35 | 8-K |
| Q4 FY2024 | Tue, Feb 18, 2025 | before open | 49 | 8-K |
What they guided beta
| Q3 FY2026 | "The Company anticipates topline results from the SUMMIT Phase 3 trial in the second half of 2027." exhibit |
| Q3 FY2026 | "The Company anticipates topline results from both studies in the second half of 2027." exhibit |
| Q3 FY2026 | "Target enrollment in the trial has been reached, and the Company anticipates topline results in the first quarter of 2027." exhibit |
| Q3 FY2026 | "The Company anticipates topline results from SUSTAIN in the second half of 2027." exhibit |
| Q3 FY2026 | "The Company anticipates completion of enrollment in CLARITY in the first half of 2027. 3" exhibit |
| Q2 FY2026 | "Smoking Cessation: Axsome is on track to initiate a pivotal Phase 2/3 trial of AXS-05 in smoking cessation in the third quarter of 2026." exhibit |
| Q2 FY2026 | "The Company anticipates topline results from the ENGAGE Phase 3 trial in the fourth quarter of 2026." exhibit |
| Q2 FY2026 | "The Company anticipates topline results from the SUSTAIN Phase 3 trial in 2027." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AXSM
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AXSM
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/AXSM/"><img src="https://veritasdata.dev/embed/AXSM.svg" alt="AXSM earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/AXSM/)
Script
<script async src="https://veritasdata.dev/embed/AXSM.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AXSM"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.